Sars-cov-2 mrna-1273 (6m-5y) vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sars-cov-2 mrna-1273 (6m-5y) vaccine
E
- efalizumab
- efgartigimod alfa
- efgartigimod alfa / hyaluronidase
- eflornithine
- elivaldogene autotemcel
- Ellence (epirubicin)
- elotuzumab
- Eloxatin (oxaliplatin)
- elranatamab
- Elrexfio (elranatamab)
- Elspar (asparaginase escherichia coli)
- Emflaza (deflazacort)
- Empliciti (elotuzumab)
- Enbrel (etanercept)
- enfortumab vedotin
- Engerix-B (hepatitis b adult vaccine)
- Engerix-B Pediatric (hepatitis b pediatric vaccine)
- Enhertu (fam-trastuzumab deruxtecan)
- Enspryng (satralizumab)
- Entocort EC (budesonide)
- Entyvio (vedolizumab)
- Entyvio Pen (vedolizumab)
- Envarsus XR (tacrolimus)
- Eohilia (budesonide)
- epcoritamab
- epirubicin
- Epkinly (epcoritamab)
- Erelzi (etanercept)
- Ergamisol (levamisole)
- eribulin
- etanercept
- Eticovo (etanercept)
- Etopophos (etoposide)
- etoposide
- etrasimod
- everolimus
- Evomela (melphalan)
- Evusheld (cilgavimab / tixagevimab)
- exagamglogene autotemcel
More about sars-cov-2 mrna-1273 (6m-5y) vaccine
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.